Bullish Moving Averages
14
Bearish Moving Averages
2
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
346.60Today’s High
358.3052W low
175.0052W High
470.00Open Price
354.00Prev. Close
324.6500Volume
18501.00Value
6526227.75Fundamentals
Market Cap Cr
567.30
Price to Earnings
38.90
Price to Book Value
3.20
Dividend Yield
0.00
PE to Growth
1.00
Op Revenue TTM Cr
154.37
Net Profit TTM Cr
14.60
Cash From Operating Activity Cr
-0.15
Return on Equity %
8.28
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
04 Jul, 2024
53
Week
61
Month
72.7
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
352.53
PIVOT
First Resistance
358.52
Second Resistance
364.28
Third Resistance
370.27
First Support
346.77
Second Support
340.78
Third Support
335.02
Relative Strength Index
60.44
Money Flow Index
66.2
MACD
1.66
MACD Signal
-1.2
Average True Range
15.97
Average Directional Index
15.32
Rate of Change (21)
8.21
Rate of Change (125)
0.6
Commodity Channel Index
182.7
Williams %R
-21.4
BETA
1 Month
0.64
3 Month
0.6
1 Year
0.61
3 Year
0.28
PRICE CHANGE ANALYSIS
↑ 1.88%
1 Week
Low
High
330.55
363
↑ 2.9%
1 Month
Low
High
315
363
↓ -7.87%
3 Months
Low
High
315
398.9
↑ 1.63%
6 Months
Low
High
315
470
↑ 88.08%
1 Year
Low
High
175
470
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 40.03 | 33.16 | 32.49 | 32.10 | 44.71 | 29.62 | 23.09 | 24.96 | 32.80 | 32.28 | 23.64 | |
| Operating Expenses Qtr | 33.92 | 25.75 | 25.86 | 25.89 | 36.60 | 24.29 | 19.29 | 20.44 | 28.05 | 28.02 | 21.01 | |
| Operating Profit Qtr | 5.22 | 4.02 | 5.72 | 5.24 | 6.69 | 4.22 | 3.14 | 3.13 | 3.98 | 2.55 | 2.04 | |
| EBIDT Qtr Cr | 6.11 | 7.41 | 6.64 | 6.22 | 8.12 | 5.33 | 3.80 | 4.52 | 4.74 | 4.27 | 2.63 | |
| Depreciation Qtr | 0.41 | 0.30 | 0.28 | 0.26 | 0.37 | 0.38 | 0.31 | 0.27 | 0.26 | 0.24 | 0.23 | |
| Net Profit Qtr | 3.64 | 5.50 | 4.24 | 4.19 | 5.13 | 3.93 | 3.64 | 3.01 | 3.02 | 2.77 | 1.85 | |
| Basic EPS Qtr | 2.26 | 3.48 | 2.60 | 2.69 | 3.29 | 2.53 | 2.34 | 1.93 | 1.94 | 1.77 | 1.19 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 137.79 | 122.38 | 109.72 | 74.21 | 66.48 | |
| Operating Expenses Annual Cr | 111.28 | 100.61 | 94.16 | 64.81 | 59.39 | |
| Operating Profit Annual | 20.32 | 17.17 | 11.00 | 5.21 | 1.38 | |
| Operating Profit Margin Annual % | 14.75 | 14.03 | 10.02 | 7.02 | 2.08 | |
| Total Expenses Annual Cr | 114.43 | 102.93 | 95.79 | 66.70 | 61.25 | |
| EBIDT Annual Cr | 26.51 | 21.77 | 15.56 | 9.40 | 7.09 | |
| EBIDT Annual margin % | 19.24 | 17.79 | 14.18 | 12.67 | 10.67 | |
| Depreciation | 1.24 | 1.34 | 0.96 | 1.14 | 1.15 | |
| PAT Before ExtraOrdinary Items Annual Cr | 17.57 | 15.72 | 10.53 | 6.16 | 4.46 | |
| Net Profit Annual | 17.57 | 15.72 | 10.53 | 6.16 | 4.46 | |
| Basic EPS Annual | 11.03 | 10.09 | 6.76 | 3.98 | 2.89 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 222.92 | 195.93 | 178.03 | 162.93 | 151.65 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 0.17 | 0.07 | 0.28 | 0.38 | 0.39 | |
| Total Current Liabilities Annual Cr | 64.37 | 56.42 | 53.99 | 32.53 | 22.08 | |
| Total Capital Plus Liabilities Annual Cr | 287.47 | 252.42 | 232.29 | 195.85 | 174.11 | |
| Fixed Assets Annual | 21.67 | 16.39 | 14.18 | 6.94 | 7.67 | |
| Total Non Current Assets Annual | 145.98 | 137.65 | 134.57 | 124.09 | 118.09 | |
| Total Current Assets Annual | 141.49 | 114.77 | 97.72 | 71.76 | 56.02 | |
| Total Assets Annual | 287.47 | 252.42 | 232.29 | 195.85 | 174.11 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 0.76 | 0.76 | 0.76 | 0.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | -1.19 | 6.10 | 5.21 | 6.13 | 7.29 | |
| Cash from Investing Activity Annual | -10.10 | 6.24 | -16.08 | -5.35 | -10.08 | |
| Cash from Financing Annual Activity | 11.40 | 3.04 | 7.55 | 2.27 | 1.44 | |
| Net Cash Flow Annual | - | 15.39 | -3.32 | 3.05 | -1.35 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 138.61 | 125.74 | 114.25 | 105.16 | 98.25 | |
| ROE Annual % | 7.88 | 8.02 | 5.91 | 3.77 | 2.93 | |
| ROCE Annual % | 11.32 | 10.42 | 8.18 | 5.05 | 3.90 | |
| Total Debt to Total Equity Annual | 0.14 | 0.11 | 0.11 | 0.09 | 0.08 | |
| EBDIT Annual Margin % | 20.14 | 18.48 | 14.79 | 13.43 | 11.66 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 45.29 | 34.75 | 41.69 | 37.12 | 46.50 | 30.66 | 30.94 | 34.42 | 36.99 | 35.74 | 23.74 | |
| Operating Expenses Qtr | 37.74 | 29.51 | 32.58 | 30.38 | 39.26 | 25.99 | 26.74 | 30.03 | 31.56 | 33.67 | 19.91 | |
| Operating Profit Qtr | 7.08 | 2.28 | 8.62 | 6.18 | 6.21 | 3.98 | 3.95 | 3.42 | 5.05 | 0.76 | 3.66 | |
| EBIDT Qtr Cr | 7.55 | 5.24 | 9.11 | 6.74 | 7.23 | 4.67 | 4.19 | 4.39 | 5.43 | 2.07 | 3.83 | |
| Depreciation Qtr | 0.93 | 0.81 | 0.82 | 0.79 | 0.91 | 0.93 | 0.89 | 0.82 | 1.13 | 0.20 | 0.70 | |
| Net Profit Qtr | 3.59 | 2.91 | 4.74 | 3.36 | 3.56 | 2.37 | 2.43 | 2.09 | 2.90 | 1.12 | 2.16 | |
| Basic EPS Qtr | 2.24 | 1.85 | 2.93 | 2.15 | 2.29 | 1.52 | 1.56 | 1.34 | 1.86 | 0.72 | 1.39 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 158.85 | 142.52 | 117.14 | 71.19 | 57.45 | |
| Operating Expenses Annual Cr | 130.22 | 122.03 | 103.87 | 63.33 | 53.12 | |
| Operating Profit Annual | 24.15 | 17.57 | 10.37 | 5.19 | 0.20 | |
| Operating Profit Margin Annual % | 15.21 | 12.33 | 8.85 | 7.29 | 0.34 | |
| Total Expenses Annual Cr | 139.50 | 130.50 | 107.53 | 66.07 | 55.84 | |
| EBIDT Annual Cr | 28.63 | 20.48 | 13.28 | 7.86 | 4.32 | |
| EBIDT Annual margin % | 18.03 | 14.37 | 11.34 | 11.04 | 7.52 | |
| Depreciation | 3.35 | 3.55 | 2.47 | 1.99 | 2.00 | |
| PAT Before ExtraOrdinary Items Annual Cr | 13.58 | 8.28 | 6.21 | 3.77 | 0.84 | |
| Net Profit Annual | 14.60 | 10.45 | 7.37 | 3.67 | 0.84 | |
| Basic EPS Annual | 9.17 | 6.71 | 4.73 | 2.37 | 0.55 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 176.29 | 151.60 | 139.09 | 127.13 | 118.25 | |
| Minority Interest Liability Annual Cr | -0.62 | -1.02 | 1.21 | 2.35 | 2.22 | |
| Total Non Current Liabilities Annual Cr | 0.17 | 0.07 | 0.28 | 0.38 | 0.39 | |
| Total Current Liabilities Annual Cr | 64.22 | 68.87 | 69.28 | 73.32 | 21.97 | |
| Total Capital Plus Liabilities Annual Cr | 240.06 | 219.52 | 209.85 | 203.18 | 142.83 | |
| Fixed Assets Annual | 67.94 | 67.84 | 46.64 | 95.44 | 61.13 | |
| Total Non Current Assets Annual | 94.07 | 93.12 | 95.74 | 122.81 | 87.05 | |
| Total Current Assets Annual | 145.99 | 126.40 | 114.10 | 80.36 | 55.79 | |
| Total Assets Annual | 240.06 | 219.52 | 209.85 | 203.18 | 142.83 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 0.76 | 0.76 | 5.80 | 5.57 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | -0.15 | 2.59 | 5.78 | 45.66 | 3.75 | |
| Cash from Investing Activity Annual | -9.54 | 7.92 | -15.25 | -37.57 | -10.45 | |
| Cash from Financing Annual Activity | 8.81 | -0.72 | 7.03 | 1.61 | 1.57 | |
| Net Cash Flow Annual | - | 9.78 | -2.44 | 9.70 | -5.14 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 109.23 | 96.64 | 90.03 | 83.56 | 78.05 | |
| ROE Annual % | 8.28 | 6.89 | 5.29 | 2.88 | 0.71 | |
| ROCE Annual % | 14.37 | 11.24 | 7.69 | 4.52 | 1.92 | |
| Total Debt to Total Equity Annual | 0.18 | 0.15 | 0.15 | 0.12 | 0.11 | |
| EBDIT Annual Margin % | 18.54 | 14.67 | 11.62 | 11.47 | 8.10 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Dipak Kanayalal Shah | 3.11 | 74504232 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Bhavin Mukund Mehta | 20.92 | 74504218 | 0 | 7.43 |
| Mukund Mehta | 7.09 | 74504219 | 0 | 21.92 |
| Kilitch Company (Pharma) Limited | 41.22 | 74504221 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|
| Name | Holding Percent | Holding Id |
|---|---|---|
| Dipak Kanayalal Shah | 3.11 | 74504232 |
| HUF | 1.18 | 74504226 |
| Sherni Shares Limited | 1.05 | 74504229 |
| Investor Education And Protection Fund Authority Ministry Of Corporate Affairs | 1.45 | 74504235 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Sep 20, 2019 | 0.5 | FINAL | - | Equity Share |
| Sep 18, 2018 | 0.5 | FINAL | - | Equity Share |
| Sep 24, 2012 | 30 | SPECIAL | Sep 25, 2012 | Equity Share |
| Aug 18, 2011 | 1 | FINAL | - | Equity Share |
| Oct 14, 2010 | 1 | FINAL | Oct 15, 2010 | Equity Share |
| Sep 10, 2009 | 1 | FINAL | - | Equity Share |
| Sep 10, 2008 | 1 | FINAL | - | Equity Share |
| Nov 15, 2007 | 1 | INTERIM | Nov 16, 2007 | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 27, 2024 | Quarterly Results | - |
| Feb 08, 2024 | Quarterly Results | - |
| Nov 09, 2023 | Quarterly Results | - |
| Aug 11, 2023 | Quarterly Results | - |
| Jul 22, 2023 | Others | To consider and approve conversion of warrants into the equity shares of the Company to the specified person only. |
| May 29, 2023 | Audited Results | - |
| Feb 14, 2023 | Quarterly Results | - |
| Nov 14, 2022 | Quarterly Results | - |
| Aug 10, 2022 | Quarterly Results | - |
| May 26, 2022 | Audited Results | - |
| Feb 14, 2022 | Quarterly Results | - |
| Nov 12, 2021 | Quarterly Results | - |
| Aug 13, 2021 | Quarterly Results | - |
| Jun 22, 2021 | Audited Results | - |
| Feb 11, 2021 | Quarterly Results | - |
| Nov 13, 2020 | Quarterly Results | - |
| Sep 15, 2020 | Quarterly Results | - |
| Aug 28, 2020 | Others | - |
| Jun 30, 2020 | Audited Results | - |
| May 25, 2020 | Others | Inter alia, to consider and approve the allotment of Equity Shares pursuant to exercise of option granted to employees of the Company under ESOS Scheme. |
| Feb 14, 2020 | Quarterly Results & Others | - |
| Dec 12, 2019 | Others | Inter alia, to consider and approve the proposal for investing in setting up of new green field project in Ethiopia. |
| Nov 13, 2019 | Quarterly Results | - |
| Sep 19, 2019 | Quarterly Results | inter alia, to consider and approve un-audited consolidated financial results of the company for the quarter ended June 30th, 2019. |
| Aug 22, 2019 | Others | - |
| Aug 13, 2019 | Quarterly Results | - |
| May 30, 2019 | Audited Results & Dividend | - |
| May 03, 2019 | Others | Inter alia, to consider and approve the allotment of Equity Shares pursuant to exercise of option granted to employees of the Company under ESOS Scheme. |
| Feb 12, 2019 | Quarterly Results & Others | - |
| Nov 07, 2018 | Quarterly Results & Others | - |
| Aug 31, 2018 | Others | To consider the conversion of 16,00,000 Warrants issued at a price of Rs. 59/- per warrant & allotment of 16,00,000 Equity shares of face value of Rs. 10/- each pursuant to such conversion of Warrants |
| Aug 13, 2018 | Quarterly Results & Others | - |
| Jun 28, 2018 | Others | To consider appointment of Shri Venkita Subramanian Rajan (DIN:00059146) as an Additional Director. |
| May 25, 2018 | Audited Results & Final Dividend | - |
| Mar 29, 2018 | Others | To consider the conversion of 5,00,000 Warrants issued at a price of Rs. 59/- per warrant and allotment of 5,00,000 Equity shares of face value of Rs. 10/- each pursuant to such conversion of Warrants |
| Mar 16, 2018 | Others | To consider appointment of Additional Director. |
| Feb 14, 2018 | Quarterly Results | - |
| Nov 14, 2017 | Quarterly Results | - |
| Sep 20, 2017 | Others | 1. To consider appointment of the Company Secretary and Compliance Officer of the Com. 2. To take note of the outgoing Company Secretary of the Company. |
| Aug 23, 2017 | Others | To consider, adopt and approve the Notice of the 25th AGM along with all relevant annexure for financial year 2016-17. |
| Aug 14, 2017 | Quarterly Results | - |
| Jul 25, 2017 | Others | - |
| May 30, 2017 | Audited Results | - |
| Feb 13, 2017 | Quarterly Results & Others | To consider grant of additional options to the employees of the Company under ESOP Scheme. |
| Nov 14, 2016 | Quarterly Results | - |
| Aug 12, 2016 | Quarterly Results | - |
| May 30, 2016 | Audited Results | - |
| Mar 11, 2016 | Others | To consider entering into an Agreement with respect to capital contribution with Arham Neeta Realities LLP,. |
| Feb 12, 2016 | Quarterly Results | Adoption of SEBI (Listing Obligations and Disclosure Requirements] Regulations, 2015. |
| Nov 11, 2015 | Quarterly Results | - |
| Aug 14, 2015 | Quarterly Results | - |
| May 28, 2015 | Audited Results | - |
| Apr 27, 2015 | Appointment & Resignation of Director | To consider and approve the terms of settlement arrived at by the Company with Aura Pharmaceuticals Inc. |
| Apr 14, 2015 | Appointment of Secretary & Others | 1. To consider appointment of Scrutinizer to oversee the Postal Ballot process of the Company. 2. Approved the investment upto USD 200,000 (approx. INR 1,25,00,000/-) in KILITCH ESTRO BIOTECH PLC. |
| Mar 31, 2015 | Appointment of Director | - |
| Feb 12, 2015 | Quarterly Results | - |
| Nov 14, 2014 | Quarterly Results | - |
| Aug 14, 2014 | Quarterly Results & Others | To finalize the date venue and time for convening 22nd Annual General Meeting of the Members of the Company. |
| May 30, 2014 | Audited Results | - |
| Feb 13, 2014 | Quarterly Results | - |
| Nov 14, 2013 | Quarterly Results | - |
| Oct 21, 2013 | Others | To consider investment in other Body Corporate pursuant to all applicable provisions of the Companies Act, 1956. |
| Oct 17, 2013 | Appointment of Additional Director | To consider appointment of Additional Director(s) on Board of the Company. |
| Aug 14, 2013 | Quarterly Results & Others | - |
| May 30, 2013 | Audited Results | - |
| Feb 12, 2013 | Quarterly Results | - |
| Jan 15, 2013 | To consider Sale of Investments | To consider sale of investments made by the Company. |
| Nov 09, 2012 | Quarterly Results | - |
| Aug 30, 2012 | Audited Results & Sp. Interim Dividend | 1. To take on record the Audited Consolidated Financial Results of the Company for the year ended March 31, 2012. 2. To adopt and approve the Notice & Directors Report of the Company. |
| Aug 09, 2012 | Quarterly Results | - |
| May 14, 2012 | Quarterly Results | - |
| Feb 06, 2012 | Quarterly Results | - |
| Nov 14, 2011 | Quarterly Results | - |
| Aug 12, 2011 | Quarterly Results | - |
| Jul 25, 2011 | Audited Results, Dividend & Others | - |
| May 14, 2011 | Quarterly Results | - |
| Feb 14, 2011 | Quarterly Results & ESOP | To consider allotment of Shares against exercise of employee stock option under ESOS KDL 2007 as approved by the Shareholders of the Company at their EGM held on May 31, 2010. |
| Nov 12, 2010 | Quarterly Results | - |
| Oct 16, 2010 | Employees Stock Option Plan | - |
| Aug 10, 2010 | Audited Results | - |
| Jul 30, 2010 | Quarterly Results | - |
| Apr 24, 2010 | Employees Stock Option Plan | inter alia, to implement the ESOS Scheme as per SEBI (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999 as amended. |
| Jan 30, 2010 | Quarterly Results | - |
| Oct 30, 2009 | Quarterly Results | - |
| Jul 31, 2009 | Quarterly Results | - |
| Jun 30, 2009 | Audited Results & Dividend | - |
| Jan 30, 2009 | Quarterly Results | - |
| Oct 27, 2008 | Quarterly Results | - |
| Sep 16, 2008 | To consider Allotment of Warrants | To issue and allot of 29,00,000 Warrants at a price of Rs 120/- per share on preferential basis to selected persons / entities. |
| Jul 31, 2008 | Quarterly Results | - |
| Jul 11, 2008 | To consider Issue of securities | inter alia, to consider issue of securities to certain selected persons / entities, on preferential basis, subject to compliance of SEBI (Disclosure & Investor Protection) Guidelines, 2000. |
| Jun 30, 2008 | To appoint Additional Directors | To appoint of Mr. Shailesh Chheda, Mr. Hemang Engineer, Mr. Deepak Shenoy & Dr. Mahalingam Vasudevan as Additional Directors. |
| Jun 21, 2008 | Audited Results & Final Dividend | - |
| Jan 28, 2008 | Quarterly Results | - |
| Oct 31, 2007 | Quarterly Results & Interim Dividend | - |
| Jul 30, 2007 | Quarterly Results | - |
| Jun 30, 2007 | Audited Results | - |
| Mar 02, 2007 | To consider allotment of equity shares | For the allotment of 335412 Equity Shares of Rs 10/- each at the price of Rs 27.00 to Promoters, on a Preferential Basis. |
| Jan 27, 2007 | Quarterly Results | - |
| Oct 28, 2006 | Quarterly Results | - |
| Sep 02, 2006 | Accounts | - |
| Jul 31, 2006 | Quarterly Results | - |
| Apr 28, 2006 | Quarterly Results | - |
| Mar 06, 2006 | Preferential Issue of shares | Inter alia, to consider issue of Equity Shares on preferential Basis to select group of persons including promoters (Revised) |
| Jan 31, 2006 | Quarterly Results | - |
| Oct 10, 2005 | Preferential Issue of shares | - |
| Aug 31, 2005 | Accounts | - |
| Jul 29, 2005 | Quarterly Results | - |
| Jul 08, 2005 | Amalgamation | - |
| Apr 30, 2005 | Quarterly Results | - |
| Jan 28, 2005 | Quarterly Results | - |
| Oct 30, 2004 | Quarterly Results | - |
| Oct 14, 2004 | Preferential Issue of shares | To cosider & allot 303333 equity shares of Rs.10/- each to the Promoter Group. (Revised) |
| Jul 30, 2004 | Quarterly Results | - |
| Apr 30, 2004 | Quarterly Results | - |
| Apr 16, 2004 | Right Issue of Equity Shares | (Revised) |
| Jan 31, 2004 | Quarterly Results | - |
| Oct 31, 2003 | Quarterly Results | - |
| Aug 29, 2003 | Accounts | - |
| Jul 31, 2003 | Quarterly Results | - |
| Apr 30, 2003 | Quarterly Results | - |
| Jan 30, 2003 | Quarterly Results | - |
| Oct 31, 2002 | Quarterly Results | - |
| Jul 31, 2002 | Quarterly Results | - |
| Apr 30, 2002 | Quarterly Results | - |
| Jan 30, 2002 | Quarterly Results | - |
| Oct 29, 2001 | Quarterly Results | - |
| Jul 30, 2001 | Quarterly Results | - |
| Apr 30, 2001 | Quarterly Results | - |
| Jan 31, 2001 | Quarterly Results | - |
| Oct 31, 2000 | Quarterly Results | - |
| Jul 31, 2000 | Quarterly Results | - |
| Apr 29, 2000 | Quarterly Results | - |
| Jan 31, 2000 | Quarterly Results | - |
| Jul 30, 1999 | Quarterly Results | - |
| Apr 30, 1999 | Quarterly Results | - |
| Jan 30, 1999 | Quarterly Results | - |
| Oct 30, 1998 | Quarterly Results | - |
| Jul 30, 1998 | Quarterly Results | - |
| May 30, 1998 | Half Yearly Results | - |
| Nov 29, 1997 | Half Yearly Results | - |
| May 30, 1997 | Half Yearly Results. | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
28 Jun 2024
KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding loss of share certificate by the shareholders
28 Jun 2024
KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of issue of duplicate share certificate to the shareholders detailed in the attached file
28 Jun 2024
KILITCH DRUGS (INDIA) LTD. - 524500 - Closure of Trading Window
Intimation of Closure of Trading window with effect from 1st July, 2024 upto 48 hours from the declaration of unaudited results for the quarter and year ended 30th June, 2024
14 Jun 2024
KILITCH DRUGS (INDIA) LTD. - 524500 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Submission of Transcript of Earning Call
10 Jun 2024
KILITCH DRUGS (INDIA) LTD. - 524500 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of earning call
05 Jun 2024
KILITCH DRUGS (INDIA) LTD. - 524500 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
we hereby inform you that the Company will be hosting an investor and analyst conference call on Monday, 10th June, 2024 at 11:00 am to discuss the performance for the quarter and financial year ended 31st March, 2024 as per the invite enclosed herewith
05 Jun 2024
KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation to the stock exchange regarding receipt of intimation of loss of share certificate by one of the shareholers
27 May 2024
KILITCH DRUGS (INDIA) LTD. - 524500 - Board Meeting Outcome for Quarterly Financial Results For The Year Ended 31St March 2024
Quarterly financial results for the year ended 31st March, 2024
27 May 2024
KILITCH DRUGS (INDIA) LTD. - 524500 - Financial Results For The Year Ended 31St March 2024
Financial Results for the year ended 31st March, 2024
20 May 2024
KILITCH DRUGS (INDIA) LTD. - 524500 - Board Meeting Intimation for Audited Financial Results For The Quarter And Year Ended 31St March, 2024
KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 ,inter alia, to consider and approve financial results for the quarter and year ended 31st March, 2024
